Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Carissa C Jones"'
Autor:
Lindsay N Sausville, Carissa C Jones, Melinda C Aldrich, William J Blot, Ambra Pozzi, Scott M Williams
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180471 (2017)
Globally, lung cancer results in more deaths worldwide than any other cancer, indicating a need for better treatments. Members of the eicosanoid metabolism pathway represent promising therapeutic targets, as several enzymes involved in the generation
Externí odkaz:
https://doaj.org/article/e65e1a27e0bd491abeee6d52aef21177
Autor:
Melinda C. Aldrich, Eric L. Grogan, Stephen J. Chanock, William J. Blot, Margaret R. Wrensch, John K. Wiencke, Ann G. Schwartz, Angela S. Wenzlaff, Dana C. Crawford, William S. Bush, Carissa C. Jones
SUPPLEMENTAL TABLE 1. Summary of the five previously reported lung cancer survival GWAS variants examined in the present study. SUPPLEMENTAL TABLE 2. Descriptive characteristics of African Americans with NSCLC participating in the KCI/WSU and UCSF st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f37868a7e39e1e096b1647208832dfa
https://doi.org/10.1158/1055-9965.22438221
https://doi.org/10.1158/1055-9965.22438221
Autor:
Melinda C. Aldrich, Eric L. Grogan, Stephen J. Chanock, William J. Blot, Margaret R. Wrensch, John K. Wiencke, Ann G. Schwartz, Angela S. Wenzlaff, Dana C. Crawford, William S. Bush, Carissa C. Jones
Background: African Americans have the highest lung cancer mortality in the United States. Genome-wide association studies (GWASs) of germline variants influencing lung cancer survival have not yet been conducted with African Americans. We examined f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1808b2fc46d566e12da893a94660c4e5
https://doi.org/10.1158/1055-9965.c.6516270.v1
https://doi.org/10.1158/1055-9965.c.6516270.v1
Autor:
Emma G Sturgill, Amanda Misch, Carissa C Jones, Daniel Luckett, Xiaotong Fu, Dan Schlauch, Suzanne F Jones, Howard A Burris, David R Spigel, Andrew J McKenzie
Publikováno v:
The oncologist. 27(3)
Background Tumor mutation burden (TMB), a biomarker for immune checkpoint inhibitor (CPI) response, is reported by both blood- and tissue-based next-generation sequencing (NGS) vendors. However, the agreement between TMB from blood (bTMB) and tissue
Autor:
Curtis C. Harris, Christopher I. Amos, Stephen J. Chanock, John K. Wiencke, Melinda C. Aldrich, Xifeng Wu, Margaret R. Spitz, Carissa C. Jones, William Blot, Ann G. Schwartz, Margaret Wrensch, Yuki Bradford
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 28, iss 4
Background: Identifying genetic variants with pleiotropic associations across multiple cancers can reveal shared biologic pathways. Prior pleiotropic studies have primarily focused on European-descent individuals. Yet population-specific genetic vari
Autor:
William S. Bush, Sarah F Mercaldo, Angela S. Wenzlaff, William J. Blot, Melinda C. Aldrich, Jeffrey D. Blume, Ann G. Schwartz, Heidi Chen, Carissa C. Jones, Stephen J. Chanock, Dana C. Crawford, Eric L. Grogan, Stephen A. Deppen
Introduction Lung cancer is a leading cause of cancer-related death worldwide. Racial disparities in lung cancer survival exist between blacks and whites, yet they are limited by categorical definitions of race. We sought to examine the impact of Afr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::568a7585f5e37fc5257f1ec9319aa4a9
https://europepmc.org/articles/PMC6153049/
https://europepmc.org/articles/PMC6153049/
Autor:
Carissa C. Jones, William J. Blot, Melinda C. Aldrich, Lindsay N. Sausville, Scott M. Williams, Ambra Pozzi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 7, p e0180471 (2017)
PLoS ONE, Vol 12, Iss 7, p e0180471 (2017)
Globally, lung cancer results in more deaths worldwide than any other cancer, indicating a need for better treatments. Members of the eicosanoid metabolism pathway represent promising therapeutic targets, as several enzymes involved in the generation
Autor:
John K. Wiencke, William J. Blot, Melinda C. Aldrich, Dana C. Crawford, Margaret Wrensch, Eric L. Grogan, Stephen J. Chanock, Carissa C. Jones, Angela S. Wenzlaff, William S. Bush, Ann G. Schwartz
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 26, iss 8
Background: African Americans have the highest lung cancer mortality in the United States. Genome-wide association studies (GWASs) of germline variants influencing lung cancer survival have not yet been conducted with African Americans. We examined f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022a341c6b0076de03c11f192d89a0b8
https://europepmc.org/articles/PMC5540773/
https://europepmc.org/articles/PMC5540773/
Autor:
Bruni A; Clinical Islet Transplant Program, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.; Department of Surgery, University of Alberta, Edmonton, AB, Canada.; Canadian National Transplant Research Program, Edmonton, AB, Canada., Pepper AR; Clinical Islet Transplant Program, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.; Department of Surgery, University of Alberta, Edmonton, AB, Canada.; Canadian National Transplant Research Program, Edmonton, AB, Canada., Pawlick RL; Clinical Islet Transplant Program, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Gala-Lopez B; Clinical Islet Transplant Program, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.; Department of Surgery, University of Alberta, Edmonton, AB, Canada.; Canadian National Transplant Research Program, Edmonton, AB, Canada., Gamble A; Clinical Islet Transplant Program, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.; Department of Surgery, University of Alberta, Edmonton, AB, Canada., Kin T; Clinical Islet Transplant Program, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Malcolm AJ; Clinical Islet Transplant Program, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.; Canadian National Transplant Research Program, Edmonton, AB, Canada., Jones C; BioMimetix JV, LLC, Englewood, CO, USA., Piganelli JD; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; BioMimetix JV, LLC, Englewood, CO, USA., Crapo JD; Department of Medicine, National Jewish Health, Denver, CO, USA.; BioMimetix JV, LLC, Englewood, CO, USA., Shapiro AMJ; Clinical Islet Transplant Program, Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.; Department of Surgery, University of Alberta, Edmonton, AB, Canada.; Canadian National Transplant Research Program, Edmonton, AB, Canada.
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2018 Aug; Vol. 18 (8), pp. 1879-1889. Date of Electronic Publication: 2018 Mar 31.
Autor:
Xu Y; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Brenning B; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Clifford A; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Vollmer D; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Bearss J; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A ; Division of Oncology of School of Medicine and Center for Investigational Therapeutics at Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 U.S.A (Current Address)., Jones C; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., McCarthy V; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Shi C; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Wolfe B; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Aavula B; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Warner S; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Bearss DJ; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A ; Division of Oncology of School of Medicine and Center for Investigational Therapeutics at Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 U.S.A (Current Address)., McCullar MV; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A., Schuch R; Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY 10065, U.S.A., Pelzek A; Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY 10065, U.S.A., Bhaskaran SS; Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY 10065, U.S.A., Stebbins CE; Laboratory of Structural Microbiology, The Rockefeller University, New York, NY, U.S.A., Goldberg AR; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A ; Avacyn Pharmaceuticals, Inc., Teaneck, NJ, U.S.A. (Current Address)., Fischetti VA; Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY 10065, U.S.A., Vankayalapati H; Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), 4140 Dublin Boulevard, Suite 200, Dublin, CA 94568, U.S.A ; Division of Oncology of School of Medicine and Center for Investigational Therapeutics at Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 U.S.A (Current Address).
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2013 Dec 12; Vol. 4 (12), pp. 1142-1147.